Tobieson, Lovisa
Zetterberg, Henrik
Blennow, Kaj
Marklund, Niklas
Funding for this research was provided by:
STROKE-Riksförbundet
Swedish State and County Councils, the ALF-agreement (ALFLIO-925101)
Vetenskapsrådet (2018-02532, 2017-00915)
Swedish State Support for Clinical Research
European Research Council (681712)
Alzheimer's Drug Discovery Foundation (201809-2016862)
Alzheimer's Association (ADSF-21-831376-C)
Olav Thon foundation
Familjen Erling-Perssons Stiftelse
Stiftelsen för Gamla Tjänarinnor
Hjärnfonden (FO2019-0228, FO2017-0243)
European Union's Horizon 2020
Dementia Research UK
Swedish Alzheimer Foundation (AF-742881)
Swedish government and the County Councils, the ALF-agreement (ALFGBG-715986)
European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236)
NIH, USA (1R01AG068398-01)
Linköping University
Article History
Received: 19 May 2021
Accepted: 3 August 2021
First Online: 20 August 2021
Competing interests
: The authors declare no competing interests.